Rheonix

The CDC says that the number of people in the US who have been infected with diseases carried by mosquitoes, ticks, and flea bites have more than tripled in recent years.

The researchers built a combination nucleic acid-antibody test for the disease using an approach they said could be generally useful for rapid test development.

Rheonix has won an administrative supplement to an existing SBIR grant to develop the Zika test using its CARD cartridge and Encompass Optimum platform.

The firm's dual assay for host antigen to HIV as well as viral RNA was described in a proof-of-principle study earlier this year. 

Rheonix Raises $28.6M

The Ithaca, New York-based firm will use the financing to ramp up commercialization of its molecular diagnostic testing platforms.

The firm is aiming at in vitro diagnostics, applied markets, and next-generation sequencing sample preparation.

The Phase II grant will provide the company with funding to develop a commercial-ready version of the test.

The fully automated self-confirming assay will simultaneously detect HIV/AIDS antibodies and viral RNA in a single specimen.

HandyLab has been awarded

Pages

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.